Valens is trading 7.74% up in pre-market at $1.81 as investors positioned ahead of its second-quarter 2026 earnings release scheduled before the August 12, 2026 opening bell.
- The company also planned an 8:30 a.m. ET conference call to discuss results; analysts expected approximately $17.40 million in revenue and a $0.07-per-share loss.
- Management previously guided for Q2 revenue of $17.2 million–$17.6 million, 60%–62% gross margin, and a $4.4 million–$4.9 million adjusted EBITDA loss.